Market closedNon-fractional
Apyx Medical/APYX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Apyx Medical
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
Ticker
APYX
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Clearwater, United States
Employees
252
Website
apyxmedical.com
Apyx Medical Metrics
BasicAdvanced
$48M
Market cap
-
P/E ratio
-$0.66
EPS
1.20
Beta
-
Dividend rate
Price and volume
Market cap
$48M
Beta
1.2
Financial strength
Current ratio
5.866
Quick ratio
4.715
Long term debt to equity
186.945
Total debt to equity
188.783
Interest coverage (TTM)
-5.69%
Management effectiveness
Return on assets (TTM)
-20.30%
Return on equity (TTM)
-80.84%
Valuation
Price to revenue (TTM)
0.947
Price to book
2.34
Price to tangible book (TTM)
2.34
Price to free cash flow (TTM)
-4.701
Growth
Revenue change (TTM)
14.25%
Earnings per share change (TTM)
9.82%
3-year revenue growth
17.18%
3-year earnings per share growth
14.95%
What the Analysts think about Apyx Medical
Analyst Ratings
Majority rating from 5 analysts.
Apyx Medical Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$10M
-30.14%
Net income
-$7.5M
-21.88%
Profit margin
-73.52%
11.82%
Apyx Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.03
-$0.13
-$0.28
-$0.22
-
Expected
-$0.07
-$0.11
-$0.18
-$0.21
-$0.20
Surprise
-56.77%
14.84%
57.66%
2.61%
-
Apyx Medical News
AllArticlesVideos
Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health
PRNewsWire·1 week ago
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
Business Wire·2 months ago
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Apyx Medical stock?
Apyx Medical (APYX) has a market cap of $48M as of July 06, 2024.
What is the P/E ratio for Apyx Medical stock?
The price to earnings (P/E) ratio for Apyx Medical (APYX) stock is 0 as of July 06, 2024.
Does Apyx Medical stock pay dividends?
No, Apyx Medical (APYX) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Apyx Medical dividend payment date?
Apyx Medical (APYX) stock does not pay dividends to its shareholders.
What is the beta indicator for Apyx Medical?
Apyx Medical (APYX) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Apyx Medical stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.